Gulf International Bank (Uk) LTD Biomarin Pharmaceutical Inc Transaction History

Gulf International Bank (Uk) LTD

$3.9 Billion
Q3 2024

A detailed history of Gulf International Bank (Uk) LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Gulf International Bank (Uk) LTD holds 14,824 shares of BMRN stock, worth $970,230. This represents 0.03% of its overall portfolio holdings.

Number of Shares

14,824

Previous 15,621 5.1%

Holding current value

$970,230

Previous $1.29 Million 19.05%

% of portfolio

0.03%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$69.02 - $93.84 $55,008 - $74,790	-797 Reduced 5.1%	14,824 $1.04 Million
Q2 2024 Jul 10, 2024	SELL	$74.43 - $92.22 $45,923 - $56,899	-617 Reduced 3.8%	15,621 $1.29 Million
Q1 2024 Apr 11, 2024	BUY	$83.81 - $99.0 $8,800 - $10,395	105 Added 0.65%	16,238 $1.42 Million
Q4 2023 Jan 11, 2024	SELL	$76.22 - $98.51 $121,037 - $156,433	-1,588 Reduced 8.96%	16,133 $1.56 Million
Q3 2023 Oct 10, 2023	SELL	$85.07 - $94.48 $178,561 - $198,313	-2,099 Reduced 10.59%	17,721 $1.57 Million
Q2 2023 Aug 02, 2023	SELL	$86.68 - $100.3 $480,120 - $555,561	-5,539 Reduced 21.84%	19,820 $1.72 Million
Q1 2023 Apr 12, 2023	SELL	$87.74 - $117.27 $572,854 - $765,655	-6,529 Reduced 20.47%	25,359 $2.47 Million
Q4 2022 Feb 08, 2023	SELL	$80.93 - $108.63 $11,734 - $15,751	-145 Reduced 0.45%	31,888 $3.3 Million
Q1 2022 May 05, 2022	SELL	$74.28 - $92.69 $66,480 - $82,957	-895 Reduced 2.72%	32,033 $2.47 Million
Q4 2021 Jan 24, 2022	SELL	$71.72 - $91.47 $351,356 - $448,111	-4,899 Reduced 12.95%	32,928 $2.91 Million
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $280,685 - $340,631	-3,756 Reduced 9.03%	37,827 $2.86 Million
Q4 2020 Feb 12, 2021	SELL	$72.61 - $90.2 $249,851 - $310,378	-3,441 Reduced 7.64%	41,583 $3.65 Million
Q3 2020 Oct 21, 2020	BUY	$71.87 - $131.03 $7,187 - $13,103	100 Added 0.22%	45,024 $3.43 Million
Q3 2019 Oct 08, 2019	SELL	$67.4 - $85.11 $29,386 - $37,107	-436 Reduced 0.96%	44,924 $3.03 Million
Q1 2019 Apr 18, 2019	BUY	$84.2 - $98.62 $50,520 - $59,172	600 Added 1.34%	45,360 $4.03 Million
Q4 2018 Jan 08, 2019	SELL	$80.14 - $106.07 $1 Million - $1.33 Million	-12,528 Reduced 21.87%	44,760 $3.81 Million
Q3 2018 Nov 05, 2018	BUY	$93.92 - $105.72 $213,668 - $240,513	2,275 Added 4.14%	57,288 $5.56 Million
Q1 2018 May 09, 2018	BUY	$77.67 - $92.63 $2,563 - $3,056	33 Added 0.06%	55,013 $4.46 Million
Q3 2017 Oct 11, 2017	BUY	$80.6 - $94.95 $4.43 Million - $5.22 Million	54,980	54,980 $5.12 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.

Account

Gulf International Bank (Uk) LTD Biomarin Pharmaceutical Inc Transaction History